Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Seto

Showing results (31-40 of 242) with videos related to

Pageof 25
Sort By:
Oncology and Therapy|July 24, 2020
Real-World EGFR T790M Testing in Advanced Non-Small-Cell Lung Cancer: A Prospective Observational Study in JapanTakashi Seto, Naoyuki Nogami, Nobuyuki Yamamoto, et al.
Surgery Today|October 5, 2011
Concurrent chemoradiotherapy using cisplatin plus S-1, an oral fluoropyrimidine, followed by surgery for selected patients with stage III non-small cell lung cancer: a single-center feasibility studyRiichiroh Maruyama, Fumihiko Hirai, Kaoru Ondo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2006
Predictive factors for interstitial lung disease, antitumor response, and survival in non-small-cell lung cancer patients treated with gefitinibMasahiko Ando, Isamu Okamoto, Nobuyuki Yamamoto, et al.
Oncotargets and Therapy|March 25, 2021
Anti-PD-1 Monotherapy for Advanced NSCLC Patients with Older Age or Those with Poor Performance StatusTaichi Matsubara, Takashi Seto, Shinkichi Takamori, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Catheter drainage followed by the instillation of bleomycin to manage malignant pericardial effusion in non-small cell lung cancer: a multi-institutional phase II trialRiichiroh Maruyama, Hideki Yokoyama, Takashi Seto, et al.
Oxford Medical Case Reports|June 2, 2020
Histological conversion from adenocarcinoma to small cell carcinoma of the lung after treatment with an immune checkpoint inhibitor: a case reportNaoko Miura, Taichi Matsubara, Shinkichi Takamori, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Co-expression of IDO1 and PD-L1 in lung squamous cell carcinoma: Potential targets of novel combination therapyKazuki Takada, Kenichi Kohashi, Mototsugu Shimokawa, et al.
The Annals of Thoracic Surgery|November 20, 2016
Pulmonary Resection for Synchronous M1b-cStage IV Non-Small Cell Lung Cancer PatientsMasafumi Yamaguchi, Makoto Edagawa, Yuzo Suzuki, et al.
The Annals of Thoracic Surgery|April 28, 2020
Surgically Resected Second Primary Lung Adenocarcinoma After Pembrolizumab AdministrationShinkichi Takamori, Taichi Matsubara, Naoki Haratake, et al.
Surgical Oncology|March 31, 2015
Preoperative concurrent chemoradiotherapy followed by extrapleural pneumonectomy for patients with non-small cell lung cancer with malignant pleural effusion and/or pleural nodules: Ten-year results of a prematurely terminated single institute phase II trialMasafumi Yamaguchi, Yukito Ichinose, Shinichiro Shimamatsu, et al.
Pageof 25

Showing results (31-40 of 242) with videos related to

Sort By:
Pageof 25
Oncology and Therapy|July 24, 2020
Real-World EGFR T790M Testing in Advanced Non-Small-Cell Lung Cancer: A Prospective Observational Study in JapanTakashi Seto, Naoyuki Nogami, Nobuyuki Yamamoto, et al.
Surgery Today|October 5, 2011
Concurrent chemoradiotherapy using cisplatin plus S-1, an oral fluoropyrimidine, followed by surgery for selected patients with stage III non-small cell lung cancer: a single-center feasibility studyRiichiroh Maruyama, Fumihiko Hirai, Kaoru Ondo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2006
Predictive factors for interstitial lung disease, antitumor response, and survival in non-small-cell lung cancer patients treated with gefitinibMasahiko Ando, Isamu Okamoto, Nobuyuki Yamamoto, et al.
Oncotargets and Therapy|March 25, 2021
Anti-PD-1 Monotherapy for Advanced NSCLC Patients with Older Age or Those with Poor Performance StatusTaichi Matsubara, Takashi Seto, Shinkichi Takamori, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Catheter drainage followed by the instillation of bleomycin to manage malignant pericardial effusion in non-small cell lung cancer: a multi-institutional phase II trialRiichiroh Maruyama, Hideki Yokoyama, Takashi Seto, et al.
Oxford Medical Case Reports|June 2, 2020
Histological conversion from adenocarcinoma to small cell carcinoma of the lung after treatment with an immune checkpoint inhibitor: a case reportNaoko Miura, Taichi Matsubara, Shinkichi Takamori, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Co-expression of IDO1 and PD-L1 in lung squamous cell carcinoma: Potential targets of novel combination therapyKazuki Takada, Kenichi Kohashi, Mototsugu Shimokawa, et al.
The Annals of Thoracic Surgery|November 20, 2016
Pulmonary Resection for Synchronous M1b-cStage IV Non-Small Cell Lung Cancer PatientsMasafumi Yamaguchi, Makoto Edagawa, Yuzo Suzuki, et al.
The Annals of Thoracic Surgery|April 28, 2020
Surgically Resected Second Primary Lung Adenocarcinoma After Pembrolizumab AdministrationShinkichi Takamori, Taichi Matsubara, Naoki Haratake, et al.
Surgical Oncology|March 31, 2015
Preoperative concurrent chemoradiotherapy followed by extrapleural pneumonectomy for patients with non-small cell lung cancer with malignant pleural effusion and/or pleural nodules: Ten-year results of a prematurely terminated single institute phase II trialMasafumi Yamaguchi, Yukito Ichinose, Shinichiro Shimamatsu, et al.
Pageof 25